Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
PUT
iShares Russell 2000 Value ETF
IWN
$14.3B
| $116K | ﹤0.01% |
900
-700
| -44% | -$86.6K |
|
5302
Pegasystems
PEGA
$5.02B
| $116K | ﹤0.01% |
2,932
-71,964
| -96% | -$2.72M |
|
5303
Twin Disc
TWIN
$329M
| $116K | ﹤0.01% |
10,525
+5,272
| +100% | +$55.1K |
|
|
NXGN
5304
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $116K | ﹤0.01% |
7,200
+1,500
| +26% | +$24.8K |
|
5305
Galectin Therapeutics
GALT
$196M
| $115K | ﹤0.01% |
40,060
+20,188
| +102% | +$70.1K |
|
5306
GSI Technology
GSIT
$215M
| $115K | ﹤0.01% |
16,179
+8,125
| +101% | +$61.5K |
|
5307
iShares Global Energy ETF
IXC
$2.79B
| $115K | ﹤0.01% |
3,737
| – | – |
|
5308
Astrana Health
ASTH
$1.76B
| $115K | ﹤0.01% |
6,249
-7,541
| -55% | -$125K |
|
5309
First Guaranty Bancshares
FGBI
$159M
| $114K | ﹤0.01% |
5,777
+2,901
| +101% | +$51.8K |
|
|
FONR
5310
DELISTED
Fonar
FONR
| $114K | ﹤0.01% |
5,802
-6
| -0.1% | -$120 |
|
5311
Mustang Bio
MBIO
$4.32M
| $114K | ﹤0.01% |
37
+19
| +106% | +$43.5K |
|
5312
CALL
Pediatrix Medical
MD
$2.18B
| $114K | ﹤0.01% |
+4,100
| New | +$103K |
|
5313
CALL
Manitowoc
MTW
$497M
| $114K | ﹤0.01% |
6,500
-6,900
| -51% | -$101K |
|
5314
PUT
Travel + Leisure Co
TNL
$4.66B
| $114K | ﹤0.01% |
2,200
-100
| -4% | -$4.79K |
|
5315
Wrap Technologies
WRAP
$103M
| $114K | ﹤0.01% |
17,831
+13,735
| +335% | +$63K |
|
|
AMAG
5316
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
| $114K | ﹤0.01% |
9,400
+7,900
| +527% | +$86.3K |
|
5317
Corporacion America
CAAP
$4.21B
| $113K | ﹤0.01% |
18,800
-6,965
| -27% | -$31.2K |
|
|
CRESY
5318
Cresud
CRESY
$795M
| $113K | ﹤0.01% |
16,828
-18,713
| -53% | -$96.6K |
|
5319
CALL
Louisiana-Pacific
LPX
$5.06B
| $113K | ﹤0.01% |
3,800
+2,200
| +138% | +$62.1K |
|
5320
PUT
Pacira BioSciences
PCRX
$1.04B
| $113K | ﹤0.01% |
2,500
| – | – |
|
5321
CALL
ProShares Ultra Gold
UGL
$650M
| $113K | ﹤0.01% |
9,200
| – | – |
|
|
JCP
5322
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $113K | ﹤0.01% |
101,300
-2,900
| -3% | -$3.08K |
|
|
AKRO
5323
DELISTED
Akero Therapeutics
AKRO
| $112K | ﹤0.01% |
5,018
+2,361
| +89% | +$48.8K |
|
5324
PUT
Darling Ingredients
DAR
$9.64B
| $112K | ﹤0.01% |
4,000
+2,400
| +150% | +$53.5K |
|
5325
CALL
Tidewater
TDW
$3.73B
| $112K | ﹤0.01% |
5,800
| – | – |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.